Search Results

There are 10629 results for: content related to: AUGMENTATION OF FLUOXETINE WITH LOVASTATIN FOR TREATING MAJOR DEPRESSIVE DISORDER, A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED-CLINICAL TRIAL

  1. Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 4, October 1999, Pages: 358–366, John D. Rogers, Jamie Zhao, Lida Liu, Raju D. Amin, Kathleen D. Gagliano, Arturo G. Porras, Robert A. Blum, Michael F. Wilson, Michael Stepanavage and Jose M. Vega

    Version of Record online : 14 OCT 1999, DOI: 10.1053/cp.1999.v66.a101208

  2. Comparative Pharmacokinetics of Lovastatin Extended-Release Tablets and Lovastatin Immediate-Release Tablets in Humans

    The Journal of Clinical Pharmacology

    Volume 42, Issue 2, February 2002, Pages: 198–204, Jim X. Sun, Robert Niecestro, Gale Phillips, Jason Shen, Peter Lukacsko and Lawrence Friedhoff

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912700222011111

  3. Combined spectroscopic and molecular docking approach to probing binding interactions between lovastatin and calf thymus DNA

    Luminescence

    Volume 30, Issue 7, November 2015, Pages: 1004–1010, C.-B. Chen, J. Chen, J. Wang, Y.-Y. Zhu and J.-H. Shi

    Version of Record online : 1 FEB 2015, DOI: 10.1002/bio.2851

  4. You have free access to this content
    Lovastatin inhibits the growth and survival pathway of phosphoinositide 3-kinase/protein kinase B in immortalized rat brain neuroblasts

    Journal of Neurochemistry

    Volume 94, Issue 5, September 2005, Pages: 1277–1287, Maria Isabel Cerezo-Guisado, Luis Jesus Garcia-Marin, Maria Jesus Lorenzo and Maria Julia Bragado

    Version of Record online : 8 AUG 2005, DOI: 10.1111/j.1471-4159.2005.03345.x

  5. Physiological, morphological and kinetic aspects of lovastatin biosynthesis by Aspergillus terreus

    Biotechnology Journal

    Volume 4, Issue 5, May 2009, Pages: 647–664, Marcin Bizukojc and Stanislaw Ledakowicz

    Version of Record online : 18 MAY 2009, DOI: 10.1002/biot.200800289

  6. Pharmacokinetics of lovastatin extended-release dosage form (Lovastatin XL) in healthy volunteers

    Biopharmaceutics & Drug Disposition

    Volume 23, Issue 4, May 2002, Pages: 143–149, Michael Lamson, Gale Phillips, Jason Shen, Peter Lukacsko, Lawrence Friedhoff and Robert M. Niecestro

    Version of Record online : 9 MAY 2002, DOI: 10.1002/bdd.304

  7. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid

    Clinical Pharmacology & Therapeutics

    Volume 63, Issue 4, April 1998, Pages: 397–402, Teemu Kantola, Kari T. Kivistö and Pertti J. Neuvonen

    Version of Record online : 3 APR 1998, DOI: 10.1016/S0009-9236(98)90034-0

  8. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

    Clinical Pharmacology & Therapeutics

    Volume 60, Issue 1, July 1996, Pages: 54–61, Pertti J. Neuvonen and Kirsi-Maija Jalava

    Version of Record online : 1 JUL 1996, DOI: 10.1016/S0009-9236(96)90167-8

  9. You have free access to this content
    Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells

    Journal of Neurochemistry

    Volume 89, Issue 1, April 2004, Pages: 168–178, Zhihong Jiang, Xiao Zheng, Richard A. Lytle, Ryuji Higashikubo and Keith M. Rich

    Version of Record online : 20 FEB 2004, DOI: 10.1111/j.1471-4159.2004.02319.x

  10. You have free access to this content
    Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal

    International Journal of Cancer

    Volume 134, Issue 2, 15 January 2014, Pages: 268–279, Nima Niknejad, Ivan Gorn-Hondermann, Laurie Ma, Stephanie Zahr, Stephanie Johnson-Obeseki, Martin Corsten and Jim Dimitroulakos

    Version of Record online : 1 AUG 2013, DOI: 10.1002/ijc.28369

  11. You have full text access to this OnlineOpen article
    A statin-regulated microRNA represses human c-Myc expression and function

    EMBO Molecular Medicine

    Volume 4, Issue 9, September 2012, Pages: 896–909, Apana A. L. Takwi, Yan Li, Lindsey E. Becker Buscaglia, Jingwen Zhang, Saibyasachi Choudhury, Ae Kyung Park, Mofang Liu, Ken H. Young, Woong-Yang Park, Robert C. G. Martin and Yong Li

    Version of Record online : 7 AUG 2012, DOI: 10.1002/emmm.201101045

  12. Lovastatin Differentially Affects Neuronal Cholesterol and Amyloid-β Production in vivo and in vitro

    CNS Neuroscience & Therapeutics

    Volume 21, Issue 8, August 2015, Pages: 631–641, Aydé Mendoza-Oliva, Patricia Ferrera, Jorge Fragoso-Medina and Clorinda Arias

    Version of Record online : 20 JUN 2015, DOI: 10.1111/cns.12420

  13. You have free access to this content
    Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism

    International Journal of Cancer

    Volume 100, Issue 1, 1 July 2002, Pages: 111–118, Wojciech Feleszko, Izabela Młynarczuk, Dominika Olszewska, Ahmad Jalili, Tomasz Grzela, Witold Lasek, Grażyna Hoser, Grażyna Korczak-Kowalska and Marek Jakóbisiak

    Version of Record online : 6 MAY 2002, DOI: 10.1002/ijc.10440

  14. You have free access to this content
    Induction of Apoptosis by Lovastatin through Activation of Caspase-3 and DNase II in Leukaemia HL-60 Cells

    Pharmacology & Toxicology

    Volume 86, Issue 2, February 2000, Pages: 83–91, Ing-Kae Wang, Shoei-Yn Lin-Shiau and Jen-Kun Lin

    Version of Record online : 28 JUN 2008, DOI: 10.1034/j.1600-0773.2000.pto860207.x

  15. You have free access to this content
    Lovastatin arrests CHO cells between the origin decision point and the restriction point

    FEBS Letters

    Volume 484, Issue 2, November 03, 2000, Pages: 108–112, Jia-Rui Wu and David M. Gilbert

    Version of Record online : 31 OCT 2000, DOI: 10.1016/S0014-5793(00)02135-9

  16. Lovastatin: A New Cholesterol-Lowering Agent

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 7, Issue 6, November-December 1987, Pages: 198–209, Julie J. Krukemyer and Robert L. Talbert

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1987.tb03524.x

  17. You have free access to this content
    Lovastatin inhibits amyloid precursor protein (APP) β-cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid rafts

    Journal of Neurochemistry

    Volume 105, Issue 4, May 2008, Pages: 1536–1549, Je-Seong Won, Yeong-Bin Im, Mushfiquddin Khan, Miguel Contreras, Avtar K. Singh and Inderjit Singh

    Version of Record online : 5 FEB 2008, DOI: 10.1111/j.1471-4159.2008.05283.x

  18. Lovastatin

    Cardiovascular Drug Reviews

    Volume 7, Issue 2, June 1989, Pages: 89–109, A. W. Alberts, J. S. MacDonald, A. E. Till and J. A. Tobert

    Version of Record online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1989.tb00519.x

  19. Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and Lovastatin

    The Journal of Clinical Pharmacology

    Volume 30, Issue 12, December 1990, Pages: 1128–1135, Dr. Henry Y. Pan, Dr. Arthur R. DeVault, Dr. David Wang-Iverson, Dr. Eugene Ivashkiv, Dr. Brian N. Swanson and Dr. A. Arthur Sugerman

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1990.tb01856.x

  20. Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 5, May 2001, Pages: 340–345, Carl Kyrklund, Janne T. Backman, Kari T. Kivistö, Mikko Neuvonen, Jouko Laitila and Pertti J. Neuvonen

    Version of Record online : 2 MAY 2001, DOI: 10.1067/mcp.2001.115542